chr1-159928626-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_001135050.2(IGSF9):c.2762G>A(p.Gly921Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000309 in 1,488,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001135050.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152026Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000853 AC: 1AN: 117178 AF XY: 0.0000169 show subpopulations
GnomAD4 exome AF: 0.0000329 AC: 44AN: 1336970Hom.: 0 Cov.: 35 AF XY: 0.0000246 AC XY: 16AN XY: 651618 show subpopulations
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152026Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74250 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2762G>A (p.G921E) alteration is located in exon 19 (coding exon 18) of the IGSF9 gene. This alteration results from a G to A substitution at nucleotide position 2762, causing the glycine (G) at amino acid position 921 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at